Laboratory Corporation of America Holdings (LH)

NYSE: LH · IEX Real-Time Price · USD
271.57
0.70 (0.26%)
At close: Jan 21, 2022 4:00 PM
270.00
-1.57 (-0.58%)
After-hours:Jan 21, 2022 7:18 PM EST
Market Cap25.99B
Revenue (ttm)16.55B
Net Income (ttm)2.76B
Shares Out95.70M
EPS (ttm)28.19
PE Ratio9.63
Forward PE16.92
Dividendn/a
Ex-Dividend Daten/a
Volume1,989,346
Open272.79
Previous Close270.87
Day's Range270.88 - 275.25
52-Week Range212.85 - 317.17
Beta1.03
AnalystsStrong Buy
Price Target342.57 (+26.1%)
Earnings DateFeb 10, 2022

About LH

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides ...

IndustryHealth Care Providers & Services
Founded1971
CEODavid King
Employees70,000
Stock ExchangeNYSE
Ticker SymbolLH
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 17 analysts, the average rating for LH stock is "Strong Buy." The 12-month stock price forecast is 342.57, which is an increase of 26.14% from the latest price.

Price Target
$342.57
(26.14% upside)
Analyst Consensus: Strong Buy

News

LabCorp (LH) Gains As Market Dips: What You Should Know

LabCorp (LH) closed at $271.57 in the latest trading session, marking a +0.26% move from the prior day.

2 days ago - Zacks Investment Research

5 Lucrative PEG Stocks for Value Investors

Here are five value stocks, ACI, LH, PSX, FDX and SWRAY, matching our criteria.

Other symbols:ACIFDXPSX
5 days ago - Zacks Investment Research

LabCorp (LH) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, LabCorp (LH) closed at $276.08, marking a -0.62% move from the previous day.

1 week ago - Zacks Investment Research

We have no upfront costs for our Covid tests, says Labcorp CEO

Adam Schechter, Labcorp CEO, joins 'Closing Bell' to discuss how it is managing the influx of Covid test requests.

1 week ago - CNBC Television

GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Po...

CLEVELAND, Jan. 12, 2022 /PRNewswire/ -- GenomOncology announced today that GenomOncology (GO) Pathology Workbench has been selected by Labcorp's OmniSeq to support the analysis and reporting of OmniSeq...

1 week ago - PRNewsWire

LabCorp (LH) Gains But Lags Market: What You Should Know

LabCorp (LH) closed at $291.94 in the latest trading session, marking a +0.11% move from the prior day.

1 week ago - Zacks Investment Research

Why LabCorp (LH) is Poised to Beat Earnings Estimates Again

LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

1 week ago - Zacks Investment Research

LABORATORY CORPORATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Laboratory Corporation of America Holdings...

NEW YORK--(BUSINESS WIRE)-- #Corporation--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Laboratory Corporation of America Ho...

1 week ago - Business Wire

Labcorp to Announce Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the fourth quarter and full year 2021 before the market opens on Thu...

1 week ago - Business Wire

4 Momentum Picks Screened on Driehaus Strategy

COWN, LH, BBWI, and ARCB qualified as the momentum picks for the day, using the Driehaus strategy.

Other symbols:ARCBBBWICOWN
1 week ago - Zacks Investment Research

SHAREHOLDER ALERT: Robbins LLP Investigates Laboratory Corporation of America Holdings (LH) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)---- $LH #invest--Laboratory Corporation of America Holdings' (LH) Prenatal Tests May be Inaccurate

1 week ago - Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Laboratory Corporation o...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Laboratory Corporat...

2 weeks ago - Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Laboratory Corporation of America Holdings (LH) on Behalf...

LOS ANGELES--(BUSINESS WIRE)---- $LH #investors--The Law Offices of Frank R. Cruz Announces Investigation of Laboratory Corporation of America Holdings (LH) on Behalf of Investors

2 weeks ago - Business Wire

Best Value Stocks to Buy for January 6th

M, LH, and SEKEY made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 6, 2022

Other symbols:M
2 weeks ago - Zacks Investment Research

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Laboratory Corporation of America Holdings ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Laboratory Corporation of America Holdings (“Labcorp” or the “Company”) (NYSE: LH) investors concer...

2 weeks ago - Business Wire

Labcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat a...

2 weeks ago - Business Wire

LabCorp (LH) Soars to 52-Week High, Time to Cash Out?

LabCorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

2 weeks ago - Zacks Investment Research

LabCorp (LH) to Expand Oncology Portfolio With Latest Buyout

LabCorp's (LH) acquisition of PGDx will position the company at the forefront of driving better patient outcomes in oncology.

3 weeks ago - Zacks Investment Research

LH vs. WST: Which Stock Should Value Investors Buy Now?

LH vs. WST: Which Stock Is the Better Value Option?

4 weeks ago - Zacks Investment Research

5 Momentum Stocks Bargain Hunters Would Love Chasing

Given the prevailing sentiment in the market, Academy Sports (ASO), Avis Budget (CAR), Laboratory Corporation (LH), Penske Automotive (PAG) and West Fraser (WFG) are expected to give handsome returns to...

Other symbols:ASOCARPAGWFG
4 weeks ago - Zacks Investment Research

Labcorp Bolsters Liquid Biopsy Capabilities With $450M PGDx Acquisition

Laboratory Corp of America Holdings (NYSE: LH) has agreed to acquire Personal Genome Diagnostics Inc (PGDx), a cancer genomics firm with a portfolio of comprehensive liquid biopsy and tissue-based produ...

1 month ago - Benzinga

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comp...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc....

1 month ago - Business Wire

Here's Why You Should Add LabCorp (LH) to Your Portfolio Now

Investors are optimistic about LabCorp's (LH) strong third-quarter 2021 results and raised guidance.

1 month ago - Zacks Investment Research

Labcorp, Quidel: Omicron Brings Covid Testing Stocks Back In Focus

Our indicative theme on Covid-19 Testing Stocks – which includes companies that produce or carry out tests for Covid-19 infections - is up by 24% year-to-date, roughly in line with the S&P 500. While we...

Other symbols:QDEL
1 month ago - Forbes

LabCorp (LH) Upgraded to Strong Buy: What Does It Mean for the Stock?

LabCorp (LH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago - Zacks Investment Research